Engineering the perfect (bacterial) cancer therapy
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in certain cases, injection of intratumoral bacteria or their antigens may conversely provide immunostimulatory effects, as demonstrated by Coley’s toxins and recent developments in bacterial cancer therapy (5, 105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
In the citing paper
“BCT is re-gaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“Many treatments, including chemotherapy and radiation, are toxic to normal tissue and cannot completely destroy all cancer cell”
BackgroundTumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Automated design of synthetic ribosome binding sites to control protein expression
Salis, H. M., Mirsky, E. A., & Voigt, C. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1568 · Cited by 1,844
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 715
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“This containment is one possible reason that attenuated Salmonella had limited success in reducing tumour growth in human trial”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563 · cited 1×
“For propulsion and sensing, bacteria have flagella that enable tissue penetratio”
BackgroundCombinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Pfleger, B. F., Pitera, D. J., Smolke, C. D., & Keasling, J. D. (2006) · Nature Biotechnology · doi:10.1038/nbt1226 · Cited by 536 · cited 1×
“, including gene copy number, promoter strength, optimized codons, bacterial metabolism, mRNA secondary structur”
Background
Cited by
Items 701–800 of 905
Ye, F., & Zheng, H. (2025) · Health engineering. · doi:10.26599/he.2025.9460011 · Cited by 2
Yu, B., Shi, L., Duan, W., Cui, D., Manuel, E. R., & Huang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1733164 · Cited by 3
“Despite notable advances in targeted (3) and immunotherapies (4), many cancers exhibit high recurrence rates and poor prognoses, highlighting the urgent need for innovative therapeutic strategies.”
Oncolytic Probiotics with Molecular Pili for Solid Tumor Therapy
Ge, H., Ding, C., Yang, X., Gao, S., Yang, C., Hou, Y., Wang, H., Bian, L., Zhong, H., Qu, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202517989 · Cited by 2
“Only the first phase of the MP coating (0 - 6 h) is essential to try to prevent the washout of the bacteria by the hemodynamic action [ 33, 34 ].”
Lin, J., Li, B., Wang, X., Zhou, Y., Song, J., Song, J., Tang, J., Hao, H., Ji, Y., Liu, Z., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102992 · Cited by 2
“Unlike conventional type 1 dendritic cells (cDC1), which primarily perform cross-presentation in lymphoid organs, moDCs are uniquely equipped to execute this function directly in peripheral tissues under inflammatory conditions [5].”
Biomaterials Based on Bacteria for Cancer Clinical Therapy
Liang, C., Sun, X., Xin, L., Yi, M., Ma, K., Li, Z., Ran, H., Zhu, W., Wang, Z., & Zhang, J. (2026) · Biomaterials Research · doi:10.34133/bmr.0350 · Cited by 2
The Use of Bacteria and Their Toxins as Antitumor Agents: Present and Future
Ibarra-Velázquez, L. M., Cardona-López, M. A., Cervantes-Figueroa, R. S., Ascencio-Navarrate, A. G., Becerra-Mercado, M. E., & Madriz-Elisondo, A. L. (2026) · Microorganisms · doi:10.3390/microorganisms14050964 · Cited by 2
“…of genetic attenuation, biocontainment strategies, and programmable control systems is likely to expand the range of clinically acceptable indications [81,87], accelerating the incorporation of bacterial platforms into precision oncology as adjunctive and controllable therapeutic tools [85,88].”
Modification of bacterial cells for in vivo remotely guided systems
Rybkin, I., Pinyaev, S. I., Sindeeva, O. A., German, S. V., Koblar, M., Пятаев, Н. А., Čeh, M., Gorin, D. A., Sukhorukov, G. B., & Lapanje, A. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1070851 · Cited by 2
“According to Forbes et al. (2003) bacteria used in therapy are not directed specifically to the tumor in question, and their accumulation within a tumor is a passive process (Forbes, 2010).”
BackgroundInfluentialSaini, G., & Smith, B. (2023) · The Applied Biology & Chemistry Journal · doi:10.52679/tabcj.2023.0011 · Cited by 2
Gut Bacteria-Based Cancer Therapy and Anti-Solid Tumor Mechanisms
Zhang, T., Yu, X., Yang, S., & Zhou, W.-W. (2025) · Microbiology Research · doi:10.3390/microbiolres16050092 · Cited by 2
“These capabilities rely on their inherent biological mechanisms, including gene translation machinery for producing anticancer proteins, flagella for chemotaxis, molecular detection systems, and specific gene promoter regions that respond to environmental cues [14].”
Microfluidic generation of bacterial biohybrids for magnetic guidance and content release
O’Toole, N., Allen, M. E., Contini, C., & Elani, Y. (2025) · Chemical Communications · doi:10.1039/d5cc00449g · Cited by 2
Yang, S., Nguyen, K. T., Kee, H., Lee, H., Kim, J., & Park, S. (2025) · IEEE Robotics and Automation Letters · doi:10.1109/lra.2025.3597767 · Cited by 2
“Drug delivery methods using ultrasound, microorganisms, and light each have advantages such as non-invasiveness and high targeting accuracy but are limited by drawbacks like tissue damage, immune responses, and restricted accessibility to deep regions within the body [5], [6], [7], [8], [9].”
Starvation in cancer cells: circulating arginine is good for cancer but bad for patients
Sharma, N. K., Sarode, S. C., Sarode, G. S., & Patil, S. V. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1620606 · Cited by 2
Mobiliser l’immunité innée dans le traitement des cancers
Garaude, J. (2013) · médecine/sciences · doi:10.1051/medsci/20132911014 · Cited by 3
“Par exemple, l’utilisation de souches vivantes et atténuées de la bactérie Gram-positive Listeria monocytogenes (Lm), modifiée pour exprimer un antigène tumoral, s’est avérée efficace dans différents modèles animaux précliniques de tumeurs [26, 27].”
BackgroundCho, S., Park, S. J., Choi, Y. J., Jung, H., Zheng, S., Ko, S. Y., Park, J., & Park, S. (2014) · IEEE/RAS-EMBS International Conference on Biomedical Robotics and Biomechatronics (BioRob) · doi:10.1109/biorob.2014.6913887 · Cited by 2
“typhimurium has good properties for cancer therapy especially; it is already proved that the species are the most effective bacteria for tumor killing [9, 10].”
BackgroundBacterial Predation: Natural Guns to Control Infection
Berlanga, M., Viñas, M., & Guerrero, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-28368-5_18 · Cited by 3
Factors Affecting Bacterial Propagation towards Tumor Microenvironments
Koduvayur, S. P. (2016) · MOJ Proteomics & Bioinformatics · doi:10.15406/mojpb.2016.04.00112 · Cited by 2
“Bacteria are idea active targeting DDS as they can actively penetrate tissues, home in to disease sites in response to disease-specific biomarkers extruded into the extra-cellular space, and controllably induce cytotoxicity [20].”
BackgroundInfection by Salmonella enterica Promotes or Demotes Tumor Development
Hernández-Luna, M. A., Muñoz-López, P., Aguilar-González, C. A., & Luría-Pérez, R. (2018) · InTech eBooks · doi:10.5772/intechopen.75481 · Cited by 3
“Contrary to carcinogenesis induction, infection by bacteria such as Salmonella enterica facilitates the elimination of tumor cells [11].”
BackgroundInfluentialA Portable and Visual Electrobiochemical Sensor for Lactate Monitoring in Sweat
Mohammadifar, M., & Choi, S. (2018) · IEEE International Conference on Nano/Molecular Medicine and Engineering (NANOMED) · doi:10.1109/nanomed.2018.8641665 · Cited by 4
“Recent advances in genetic manipulation and engineering have inspired exciting strategies for investigating the possibility of bacteria as diagnostics for detecting and reporting on human diseases [2-3].”
BackgroundWeerakkody, L. R., & Witharana, C. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.3.337 · Cited by 2
“Some of the anti-cancer agents expressed by genetically modified, facultative or obligate anaerobic bacteria are shown in Table I [22].”
BackgroundMethodDysbiosis of the intestinal microbiota and colorectal cancer
Coleman, O., & Haller, D. (2020) · Colorectal Neoplasia and the Colorectal Microbiome · doi:10.1016/b978-0-12-819672-4.00007-6 · Cited by 2
Bacteria recycle tumour waste to fuel immune cells
Chen, L. C., & Chen, Y. Y. (2021) · Nature · doi:10.1038/d41586-021-02639-8 · Cited by 2
Afzali, S., Doosti, A., Heidari, M., Babaei, N., Keshavarz, P., Nadem, Z., & Kahnamoei, A. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101397 · Cited by 2
Synthetic Biology in Health and Disease
van Passel, M. W. J., Lam, C. M. C., dos Santos, V. A. P. M., & Diez, M. S. (2014) · Springer eBooks · doi:10.1007/978-94-017-9196-0_1 · Cited by 2
Bactofection of sequences encoding a Bax protein peptide chemosensitizes prostate cancer tumor cells
Hernández-Luna, M. A., de León-Ortega, R. D., Hernández-Cueto, D., Gaxiola-Centeno, R., Castro-Luna, R., Martínez-Cristóbal, L., Huerta‐Yépez, S., & Lurı́a-Pérez, R. (2016) · Boletín Médico Del Hospital Infantil de México (English Edition) · doi:10.1016/j.bmhime.2017.11.037 · Cited by 2
Directed Evolution and Discovery of Nitroreductase Enzymes for Targeted Cell Ablation
Little, R. F. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17012348 · Cited by 3
Traoré, M. A. (2014) · VTechWorks (Virginia Tech) · Cited by 3
Chan-Hyams, J. V. E., Copp, J., Smaill, J. B., Patterson, A. V., & Ackerley, D. F. (2020) · doi:10.26686/wgtn.12444080.v1 · Cited by 2
CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy
Ahrberg, Y., Dallmann, J., Freitag, J., Hassan, A., Jung, C., Kiefer, J., Muralidharan, A. M., Peter, M., & Beck, J. D. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2381925 · Cited by 3
“48,49 Tal Danino (Columbia University New York, USA) talked about the design of bacteria as intratumoral bioreactors for the local production and release of therapeutics at the tumor site.”
BackgroundA recently developed approach in tumor therapy using Salmonella
Gharbavi, M., KARIMKHANLOOE, G., Amani, J., KASHIAZARI, P., & Sharafi, A. (2020) · Biotechnologia · doi:10.5114/bta.2020.97883 · Cited by 1
Photothermal Nanoheaters-Modified Spores for Safe and Controllable Antitumor Therapy
Zhang, X., Zhang, Y., Wang, N., Shen, Y., Chen, Q., Han, L., & Hu, B. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s385269 · Cited by 1
“Since then, many bacteria have been applied in oncolytic treatments, such as Salmonella, Escherichia coli, Listeria, Bifidobacterium, etc.(13,14) In”
BackgroundOrganoids as an in vitro model to study human tumors and bacteria
Liu, N., Liu, S., Xu, X., Nong, X., & Chen, H. I. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27626 · Cited by 1
“62 65 In addition, the inhibitory state and hypoxia of the tumor immune microenvironment lead to varying degrees of cell death, providing favorable conditions for bacteria to escape the host immune system elimination.”
BackgroundLi, D., Zhao, W. Z., Liang, G., Yang, D., Teng, Y., Huang, L., Lei, S., Xiong, S.-L., Li, Y., Li, Y., et al. (2024) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2024.3923 · Cited by 1
Self-Iron-Enriched Bacterial Membrane Nanovesicles for Cascade and Multi-Modal Antitumor Therapy
Li, W., Wang, R., Su, Z., Li, S., Zhao, G., Wang, Q., Cao, H., & Zhang, L. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00217 · Cited by 1
Zhang, Z., Yu, G., Hou, Q., Amirrad, F., Webster, S., Nauli, S. M., Yu, J., Yaghmai, V., Eresen, A., & Zhang, Z. (2025) · Cancers · doi:10.3390/cancers17152477 · Cited by 2
“These include immune system stimulation, selective colonization of tumors, delivery of therapeutic agents, disruption of tumor metabolism, and direct tumor cell lysis [72].”
InfluentialBacteria-Based Roles in Solid Tumors: Potential for Prevention and Treatment
Huang, J., Zhang, A., Sun, J., Fu, Y., Li, W., & Wang, Y. (2025) · Pathogens · doi:10.3390/pathogens14090874 · Cited by 2
“Through continuous research, it has been found that the proliferation of bacteria in tumors induces the migration of innate immune cells, such as macrophages, neutrophils, and dendritic cells (DCs), to the tumor [84].”
Bioglue based on natural polymers: technological advances and prospects in regeneration
Jafari, A., Jouybari, T. A., Rostaminasab, G., Seifi, Z., Abdoli, P., & Rezakhani, L. (2025) · Polymer Bulletin · doi:10.1007/s00289-025-06008-7 · Cited by 2
“When bacteria are injected into a tumor or cancer cells in a tumor or systemic form, they colonize, accumulate within, and eventually cause tumor regression [31].”
Recombinant live biotherapeutics: A new frontier in peptide drug biosynthesis and precision delivery
Chawla, M., Bhange, O., & Das, B. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.12.002 · Cited by 1
Jin, K., Zhang, Y., Huang, Y., Yu, L., Zhong, Y., Niu, L., & Wu, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504077 · Cited by 1
“Bacteria-based cancer therapy has attracted increasing interest due to its intrinsic tumor-targeting capability [26, 27].”
Tang, B., Lin, Y. N., Jiang, T., Chen, Y., Zhao, Q., Wang, S., Shen, Y., Wang, S., Wu, Q., Xie, P., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-025-02303-y · Cited by 2
“Bacterial therapies offer distinct advantages over conventional treatments, including low toxicity, specific tumor targeting [193], easy detection, and superior tissue penetration [194].”
Biointegrated Micro/Nano‐Robots: Design, Applications, and Future
Jiang, J., Huang, Y., Huang, Z., Wang, Q., Sun, J., Bao, Y., Li, X., Xue, Z., & Qiu, Z. (2026) · Small Methods · doi:10.1002/smtd.70539 · Cited by 3
In Situ Vaccination by Nanomedicine Approach for Cancer Immunotherapy
Liu, Y., Li, Y., Li, R., Gao, S., Zha, D. J., & Deng, H. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00119 · Cited by 1
Use of in vitro co-culture models to inform bacterial engineering for the treatment of solid tumours
Foschini, S., Wright, J. A., Woods, S. L., & de Nys, R. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-026-00075-9 · Cited by 1
“Upon tumour in fi ltration, bacteria are thought to chemotax towards necrotic areas of the tumour core, attracted by molecules released by dying cells 32 .”
InfluentialModular Biosurface Engineering of Magnetotactic Bacteria for Multimodal Synergistic Cancer Therapy
Li, Q., Li, W., Sun, X., Feng, F., Cheng, Z., Li, W., Yao, L., & Wang, X. (2026) · Chem & Bio Engineering · doi:10.1021/cbe.5c00177 · Cited by 1
“18 − 29 Distinct from many genera of bacteria, magnetotactic bacteria contain magnetic single domain particles in their magnetosome organelle.”
Antitumor immunotoxin expression is enhanced by Escherichia coli csrB-promoter activity
Hong, S., Lee, S., Lee, D., Kim, J., Song, M., & Lim, D. (2026) · Oncogene · doi:10.1038/s41388-026-03796-8 · Cited by 1
“The natural accumulation of acetate in the TME serves as a key regulatory signal, leading to selective activation of the therapeutic gene without external intervention, thereby driving the production of a therapeutic protein that effectively suppresses tumor growth (Fig.”
Yang, W., Li, A., Dong, B., Feng, X., & Jiang, F. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108902 · Cited by 1
Wu, L.-Y., Qiu, J.-H., Qiao, X.-Y., Li, L. Z., Qiao, L.-Y., Li, C.-Y., Sun, Y., Zhang, S.-H., Du, Z.-Z., Chang, X.-Y., et al. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100030 · Cited by 4
“Nonetheless, consistent with other regulated expression systems, activation of engineered strains can still permit leakage from the intratumoral microenvironment into the bloodstream, potentially leading to adverse effects [48].”
Sonoimmunology in cancer therapy: expanding crosstalk among ultrasound-materials-immune system
Liu, Z., Wu, P., & Yuan, L. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.116179 · Cited by 1
Programmable living therapeutics for cancer immunotherapy
Deng, Z., Niu, L., Wang, Z., Jin, Y., Yao, Z., Wan, H., Guan, N., & Ye, H. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.04.007 · Cited by 5
Hadid, M. A., Al-Shaikhli, N. H., Suhail, O. K., Hameed, S. T., & Challoob, M. A. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102292 · Cited by 2
“The anoxic area, or deoxygenated tumor tissues, encourages the growth of obligatory anaerobic bacteria [97].”
Imaging the hallmarks of cancer
Grimm, J., Kiessling, F. M., Brindle, K. M., Hanahan, D., Jain, S. K., Lambin, P., Lammers, T., Li, K. C., de Vries, I. J., Weber, W., et al. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00950-y · Cited by 3
“Although Bacillus Calmette–Guerin (BCG) is the only approved bacterial treatment for cancer (bladder cancer specifically), tumour-targeting bacteria are being actively investigated as a novel therapeutic strategy 214,215 .”
Kuhl, G. C., Devoy, C., Abbas, M., Morais, E. D. S., & Tangney, M. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18080915 · Cited by 2
Bacterial-based cancer therapy: mechanisms and therapeutic advances
Sharifi, A. H., Phong, N. H. T., Marek, A., Kamal, M. A., Al-Kodmany, S., Tran, D. B., & Yamada, T. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00524-2 · Cited by 1
“Interest in this field was later revitalized by recombinant DNA technology and an improved understanding of tumor biology, enabling the development of attenuated and engineered strains with greater therapeutic selectivity and reduced pathogenicity [20–22].”
Kazmierczak, R. A., Dino, A., Eisenstark, A., & Schatten, H. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-634-4_16 · Cited by 1
A fluorescence color-encoded lipid-supported polymeric particle
Shin, S. W., Park, K. S., Baek, C., Min, J., Cho, S., Choi, J., Kim, D., & Um, S. H. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.07.033 · Cited by 1
Application of genetically engineered Salmonella typhimurium as tumor targeting agents
Hong, Y., Park, S., Kwon, S., & Min, J. (2013) · International Conference on Control, Automation and Systems (ICCAS) · doi:10.1109/iccas.2013.6704125 · Cited by 1
“There are a lot of therapeutic approaches for cancer using bacteria because they have distinctive characteristics as anti-cancer agents as well as delivery vectors for gene therapy[3].”
BackgroundBiosynthesis and application of magnetosomes in tumor-targeting therapy
Zhang, Y., Li, A., Fu, J. F., Zhong, L., & Li, X. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00066
Reviving Previous Therapeutics by Recombinant Anaerobic Bifidobacteria
Taira, I. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.12.002324
“Live bacteria have also been used in studies of cancer treatment [8].”
BackgroundCancer vaccines: translational strategies
Maeng, H. M., & Berzofsky, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820493-1.00033-7 · Cited by 2
Ananda, M., Tokede, F. I. P. P., Ginting, S. N. B., Tifen, R. N., Madao, D. A., Pangesti, E. N. E., & Irawati, W. (2021) · Biotropika Journal of Tropical Biology · doi:10.21776/ub.biotropika.2021.009.02.01 · Cited by 1
“[16] Forbes N (2010) Engineering the perfect (bacterial) cancer therapy.”
BackgroundTheranostic Approaches Using Live Bacteria
Min, J., Duong, M. T.-Q., Thangam, R., You, S.-H., & Kang, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00056-9 · Cited by 1
Microbes used as anticancer agents and their potential application in biomedicine
Bhardwaj, S., & Bhatia, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90113-0.00010-9 · Cited by 1
The Oral Microbiome in the Development of Oral Cancer
Сергеевна, К. Е., Schegoleva, A. A., Kononova, L. A., & Denisov, E. V. (2024) · Molecular Biology · doi:10.1134/s0026893324020092 · Cited by 1
Chen, C., Zhao, H., Yuan, W., Chen, H., Wang, P., Wang, Q., Chen, C., & Song, T. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c02422 · Cited by 1
Lee, E.-B., Lim, H.-D., You, S.-H., Cheong, D., & Kim, G. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.133 · Cited by 1
Pushing the Bacterial Envelope
Gautam, S., & Spiegel, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-3146-6.00004-0 · Cited by 1
“monocytogenes, meanwhile, accumulate in cancer tissue due to entrapment in the tortuous tumor vasculature [223], chemotaxis toward nutrients released from dying cancer cells [224], and preferential growth in the tumor’s unique metabolic milieu [224], where they are also protected from attack by white blood cells due t…”
Genome Microbiology for Synthetic Applications
Mohammad, T., & Hassan, M. I. (2018) · Springer eBooks · doi:10.1007/978-981-10-8693-9_5 · Cited by 1
Yoo, S. W., Kim, H.-S., Min, J., & Lee, C. (2019) · Endoscopic Microscopy · doi:10.1117/12.2509530 · Cited by 1
Quintero, D. A., Carrafa, J., Vincent, L., Lee, H. J., Wohlschlegel, J. A., & Bermudes, D. G. (2018) · PubMed · doi:10.4014/jmb.1807.08036 · Cited by 1
Genetically engineered microbes for sustainable therapies
Sharma, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820528-0.00009-0 · Cited by 1
Advances in long DNA synthesis
Paul, S. S., Trabelsi, H., Yaseen, Y., Basu, U., Altaii, H. A., & Dhali, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821477-0.00014-3 · Cited by 1
The Evolving Role of Nanoparticles in Bacteria Mediated Cancer Therapy
Kamble, S. C., Shaikh, F. F., & Sarkar, J. (2021) · Environmental and microbial biotechnology · doi:10.1007/978-981-15-9916-3_14 · Cited by 1
Leaman, E. J. (2016) · VTechWorks (Virginia Tech) · Cited by 2
Bacteria-mediated anti-cancer therapy
Bhave, M. S. (2019) · doi:10.32657/10220/47828 · Cited by 1
Metabolic modulation of tumors with engineered bacteria for immunotherapyPreprint
Geiger, R., Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M., Geiger, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-500473/v1 · Cited by 1
Chan-Hyams, J. V. E. (2020) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17148002.v1 · Cited by 3
Molecular Farming and Anticancer Vaccine
Ratre, Y. K., Mehta, A., Shinde, S., Sinha, V., Soni, V. K., Sonkar, S. C., Shukla, D., & Vishvakarma, N. K. (2023) · Wiley eBooks · doi:10.1002/9781119874096.ch17 · Cited by 2
Cu(II)/THPTA-Mediated Thiazolidine Deprotection for Living Phages and Cell Surfaces LabelingPreprint
Ma, C., Liu, G., Sun, J., Luo, D., Yin, J. J., Yang, D., Pang, S., Hou, W., Hemu, X., Ye, B., et al. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-tndtk
Li, J., & Liu, A. P. (2025) · hLife · doi:10.1016/j.hlife.2025.05.013 · Cited by 1
“In recent years, microbial-based cancer therapy has emerged as a promising avenue, leveraging the inherent tropism of certain bacteria toward solid tumors [3 – 5].”
Sasson, C., Capin, J., Boussau, Q., Abi‐Khalil, A., Guyot, M., Mayoud, C., Fiston-Lavier, A.-S., Fristot, E., Bruyere, J., Devos, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.17.694810 · Cited by 5
“To evaluate the robustness of our differentiation system in complex physiological environments, we applied it to bacterial cancer therapy, an approach in which engineered bacteria must colonize tumors and deliver therapeutic payloads 19,52,53 .”
Engineering tumor-homing bacteria as membrane-anchored immune checkpoint-blockade interfacesPreprint
Wang, Z., Fang, C., Zhou, X., Yang, S., Shah, Y. M., Romee, R., Moon, J. J., & Li, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731477 · Cited by 1
Engineering Novel Detection and Treatment Strategies for Bacterial Therapy of Cancer
Panteli, J. T. (2015) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/6956795.0
Real-Time Bioluminescence Imaging Of Salmonella-Neoplastic Cell Interactions
Flentie, K. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7dn433m
“The cytoplasmic domain of TLRs closely resembles the IL-1 receptor cytoplasmic domain, and therefore both of these are called TIR or Toll/interleukin receptor domains [36].”
BackgroundBacterial Vectors for RNAi Delivery to Cancer Cells
Lage, H. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200030 · Cited by 1
Regulation of internalization and replication of intracellular bacterial pathogens
Bassères, E. (2011) · Figshare
Synthetic Biology Approaches to Cell Therapy
Paek, S., & Ruder, W. C. (2014) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.20120056
Tuning Salmonella for cancer therapy
Kim, H., & Choi, J. M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1006561
A Synthetic Biology Approach to Engineering New Anticancer Agents
Wesener, S. R. (2013) · UWM Digital Commons (University of Wisconsin–Milwaukee)
Diseño de un sistema de liberación controlada de agentes terapéuticos en células eucariotas.
Domínguez, E. M. D., & Camacho, E. M. (2013) · Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria
Tissue penetration of bacteria into quiescent regions of tumors
Park, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.016
Expression of Periplasmic Chaperones in Salmonella Typhimurium Reduces Its Viability In Vivo
Mertensotto, M. J., Drees, J. J., Augustin, L. B., Schottel, J. L., & Saltzman, D. A. (2014) · Current Microbiology · doi:10.1007/s00284-014-0739-9
SYNBIOBACTHER - Engineering "therapeutic" bacteria
Rodrigues, L. R., Rodrigues, J. L., Machado, C., Kluskens, L., Mota, M. S., Rocha, I., & Ferreira, E. C. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A. B., Kwong, G. A., Skalak, M., Li, H. Y., Hasty, J., Allen, K. N., & Bhatia, S. N. (2014) · DSpace@MIT (Massachusetts Institute of Technology)
Abordagens de biologia sintética para o diagnóstico e tratamento do cancro
Rodrigues, L. R. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Infection and Cancer: Multi-directorial Relationship
Shurin, M. R., Zong, J., & Keskinov, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20669-1_1
Bacterial Cancer Therapy: How Patients Might Benefit from Salmonella Infections
Chorobik, P., Czaplicki, D., Ossysek, K., & Bereta, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20669-1_16
Spatiotemporal Characterization of Stochastic Bacterial Growth in Biofilm Environment
Paek, S. (2017) · VTechWorks (Virginia Tech)
Challenge to Solid Cancer Treatment Using Bifidobacterium
Taniguchi, S. (2014) · Japanese Journal of Lactic Acid Bacteria · doi:10.4109/jslab.25.18
Medina, C., Mesa‐Pereira, B., Camacho, E. M., Flores, A., & Santero, E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7604-1_7
Engineering escherichia coli for nanoparticle synthesis and targeting of colon cancer
Pasula, R. R. (2018) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/75835
“differentiate between healthy and diseased tissue [9].”
BackgroundCharacterisation and development of aspirin inducible biosensors in E. coli Nissle 1917 and SimCellsPreprint
Chen, J. X., Steel, H., Wu, Y.-H., Wang, Y., Xu, J., Rampley, C. P. N., Thompson, I. P., Papachristodoulou, A., & Huang, W. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/414169
“Synthetic biology has the potential to engineer bacteria for disease diagnosis (1) and cancer 54 therapy (2).”
Background
Metadata
- Authors
- Forbes, N. S.
- Affiliations
- University of Massachusetts Amherst (US)
- Corresponding author
- Forbes, Neil S.
- ORCID
- Forbes, Neil S.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-14
- Volume
- 10
- Issue
- 11
- Pages
- 785-794
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3756932
- OpenAlex
- W1979507175
- Cited by
- 905
- References
- 141
- Citations by year
- 2026: 76 · 2025: 89 · 2024: 95 · 2023: 76 · 2022: 81 · 2021: 81 · 2020: 69 · 2019: 47 · 2018: 47 · 2017: 46 · 2016: 42 · 2015: 40 · 2014: 45 · 2013: 37 · 2012: 20
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA120825, CA120825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial cancer therapy, synthetic biology, Salmonella, Clostridium, tumor targeting, bacterial cytotoxicity, bacterial stability, bacterial toxicity, tumor growth control, cancer immunotherapy
- MeSH terms
- Animals, Antineoplastic Agents, Clostridium, Genetic Engineering, Humans, Neoplasms, Salmonella
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.